RNA - Avidity Biosciences, Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 24.36

Open

$ 23.92

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 23.65 - $ 24.75

52 Week Range

$ 4.83 - $ 27.66

Volume

1,034,630

Average Volume

Market Cap

1.78B

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-28-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	03-01-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	05-12-2021	03-31-2021	10-Q
13	03-15-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-11-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

to-the-moon-a-look-inside-an-etf-focused-on-companies-at-the-cutting-edge-of-innovation

To The Moon! A Look Inside An ETF Focused ...
04/18/2024 18:29:09

Where Avidity Biosciences Stands With Anal...
04/11/2024 12:00:58

Needham Reiterates Buy on Avidity Bioscien...
04/11/2024 11:23:44

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

Avidity Biosciences Filed Prospectus For P...
04/02/2024 20:24:39

-3-ASR

neuromuscular-focused-avidity-biosciences-has-complete-package---analyst-predicts-stellar-142-stock-surge

Neuromuscular Focused-Avidity Biosciences ...
03/14/2024 19:29:25

Cantor Fitzgerald initiates coverage on Avidity Biosciences highlighting a robust pipeline led by del-desiran, a promising trea...

Cantor Fitzgerald Initiates Coverage On Av...
03/14/2024 11:37:16

Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Avidity Biosciences (NASDAQ:RNA) with a Overweight rating and a...

American Airlines To Rally Around 42%? Her...
03/05/2024 14:30:15

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

A Closer Look at 5 Analyst Recommendations...
03/05/2024 12:00:46

Chardan Capital Maintains Buy on Avidity B...
03/05/2024 10:33:49

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target from $2...

why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Bitdeer Technologies Shares Are Tradin...
03/04/2024 18:29:18

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

Needham Reiterates Buy on Avidity Bioscien...
03/04/2024 18:10:40

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

avidity-biosciences-says-lead-program-shows-reversal-of-disease-progression-in-neuromuscular-disease

Avidity Biosciences Says Lead Program Show...
03/04/2024 17:28:28

New AOC 1001 data from Avidity Biosciences show reversal of disease progression in DM1 patients, using key endpoints in Phase 3...

Tesla, Spirit Airlines, New York Community...
03/04/2024 15:40:18

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

Avidity Biosciences Announced New Long-ter...
03/04/2024 12:28:38

These endpoints are the same key endpoints that will be used in the global Phase 3 HARBOR trial for people living with DM1.vidi...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

Hormel Foods Reports Upbeat Earnings, Join...
02/29/2024 16:30:35

U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.

top-3-health-care-stocks-you-may-want-to-dump-in-q1

Top 3 Health Care Stocks You May Want To D...
02/29/2024 15:40:19

As of Feb. 29, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as...

tech-stocks-set-to-rise-thursday-as-january-inflation-data-fails-to-scare-markets-small-caps-surge

Tech Stocks Set To Rise Thursday As Januar...
02/29/2024 14:20:35

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 5...

Needham Reiterates Buy on Avidity Bioscien...
02/29/2024 13:51:03

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

Chardan Capital Reiterates Buy on Avidity ...
02/29/2024 13:10:24

Chardan Capital analyst Keay Nakae reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $23 price target.